Latest News from Origin
SRT – Major contract win
We invested in AIM-quoted SRT in mid 2015 and were very pleased to note the company’s recent announcement of a major Asian contract, worth an estimated $90m over three years. We believe there will be further deals of this type, which could be transformational for the business.
New investment – Desktop Genetics
We are delighted to have participated in a seed funding round for Desktop Genetics. The company produces software used in the design and execution of genome editing experiments, a market that is experiencing enormous growth. The company’s core platform, DESKGEN, is used with the world-leading CRISPR/Cas editing technology.
Origin Capital Q2 2015 News
Please click here to read a round up of our latest news.
Co-invest with Origin Capital – update!
We are pleased to announce that we have recently been accepted as an Appointed Representative of Larpent Newton Ltd, which is authorised and regulated by the Financial Conduct Authority (“FCA”). This new status means we are now able to offer third parties the opportunity to co-invest in our transactions.
First silicon success for BluWireless Technology
Portfolio company BluWireless Technology recently received its first batch of packaged semiconductor chips featuring its novel HYDRA digital baseband technology. BWT has already incorporated the chips into a demonstrator platform – “Lightning” – which it will be showing at the forthcoming Mobile World Congress in Barcelona. Receipt of working first silicon is a major development milestone for the company: we congratulate the BWT team.
AIM-market investment: Software Radio Technology
Although our team has extensive previous experience of AIM investing, SRT is the first quoted-market investment that Origin has made. SRT provides identification systems for use in marine applications and is the dominant global player in its markets. We are excited by both the size and growth of the market opportunity, and the quality of SRT’s products and management team.
Origin backs Monica Healthcare
We are excited to have invested in Monica Healthcare, which provides wireless telemetry solutions for monitoring maternal and foetal clinical indicators during labour.
Seed funding round for Up My Sport
Origin has provided seed capital to Up My Sport, a marketplace connecting sports instructors and coaches with participants. The company also provides associated administration and payment software solutions to sports professionals. The round included several prominent private investors, and the Angel Co-Fund.
Origin CEO interviewed
Tim de Vere Green, Origin’s CEO, has recently been interviewed by Anthony Miller of TechMarketView, regarding his recent experience of angel tech investing…
Co-invest with Origin Capital
From later this year, we hope to offer individual and corporate investors the opportunity to co-invest in our transactions, most of which are EIS-eligible.
For further details, please email Tim de Vere Green at timdevg@origingroup.co.uk, or call us on 020 7733 5577.